Age-related macular degeneration (AMD) is one the most common causes of severe vision loss in people over 50 years old.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Lenore Prickett was all ears when she learned a treatment that could reverse blindness for people with dry age-related ...

A new preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR) following a ...

Post hoc analyses of the AREDS / AREDS2 studies presented at the recent American Academy of Ophthalmology meeting examined ...

The global macular degeneration treatment market is poised for significant growth, projected to expand from USD 9.1 billion ...

We all know that eating a balanced diet containing plenty of fruit and veg is good for our overall health and wellbeing, but ...

A new study found that a novel mRNA-based therapy that targets a protein called RUNX1 may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR), a disease caused by a ...

At Beilinson Hospital, we are committed to tackling this issue head-on by embracing the technological revolution in eye care.

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...

Eye diseases like glaucoma, cataracts, and conjunctivitis are some of the more common types. Find eye disease awareness and ...

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has unveiled encouraging preliminary data from the Phase 1 portion of its OCU410 ...